 | ||||||||
| health | ||||||||
| NEWS | ||||||||
| Novartis set to close heart drug study early after strong results ZURICH (Reuters) - Swiss drugmaker Novartis is set to end a late-stage clinical trial of a chronic heart failure drug early, following strong interim results. The Basel-based firm said on Monday an independent committee had unanimously recommended it close ...
| ||||||||
Cardinal says first public Mass since hospitalization Appearing weak but joyful, Cardinal Francis George greeted parishioners Sunday and thanked them for their prayers during his first public Mass since a recent hospitalization amid cancer treatment. "I'm a little weak and wobbly," George said, addressing ...
| ||||||||
| Heart Failure Patients Live Longer With Advanced Defibrillators Patients with mild heart failure live longer if they're treated with advanced defibrillators that synchronize the beating of the heart in addition to shocking it back into rhythm when it stops, a study found. The trial, presented today at the American College of ...
| ||||||||
Monday is the deadline to sign up for health law Monday is the deadline to sign up for private health insurance in the new online markets created by President Barack Obama's health care law. So far, about 4 out of every 5 people enrolling have qualified for tax credits to reduce the cost of their premiums.
| ||||||||
Wearable blood monitor could predict heart attacks Heart attacks could in future be predicted days in advance using a wearable blood monitor. Scientists have identified two biomarkers whose levels drop dramatically within two weeks of a heart attack. The discovery could lead to an early warning test that can ...
| ||||||||
| Cariprazine positive for bipolar patients - Forest, Richter BUDAPEST, March 31 (Reuters) - Hungarian drug maker Gedeon Richter and its partner Forest Laboratoriess announced positive top-line results from a Phase IIb trial of antipsychotic drug Cariprazine in patients with bipolar depression, the companies said ...
| ||||||||
GlaxoSmithKline Reports Disappointing Results for Heart Disease Drug LONDON--GlaxoSmithKline PLC (GSK) on Monday detailed disappointing results from a late-stage study of darapladib, a new heart disease drug. Initial results of the trial were announced by the company in November. For the stability study--one of two ...
| ||||||||
Test accurately rules out heart attacks in the ER People attend the American College of Cardiology's Annual Scientific Session and Expo on March 29 in Washington. A large study in Sweden found that a blood test plus the usual electrocardiogram of the heartbeat were 99 percent accurate at showing ...
| ||||||||
Achoo! These cities are the worst for spring allergies Louisville has sprung to the top of the sneeze list. Louisville is the worst city for spring allergies this year, according to the Asthma and Allergy Foundation of America (AAFA). The city ranked No. 5 last spring. The foundation, based in Landover, Md., Monday ...
| ||||||||
| Disabled woman's death highlights challenges No one can say for sure why 26-year-old Anita Hendrixson went to bed one February night and never woke again. Hendrixson possessed an IQ of about 52, a mostly sunny disposition andwhat her mother described as a childlike desire to please.
| ||||||||
| HealthStyle: How to overcome self-defeating behavior Get it to go ... Email Headlines; Sign up for our newsletter and have the top headlines from your community delivered right to your inbox. Sign up today · Opinion. In this section; – Columns; – Editorials. Top Stories. Kent Bush: Hinckley's act tilted society off axis.
| ||||||||
Adolescents' muscle strength associated with lower cardiometabolic risk 1. Children and adolescents with higher normalized strength had fewer risk factors associated with future development of metabolic disease. 2. Boys and girls with higher strength-to-BMI ratios had smaller waist circumference, higher levels of cardiovascular ...
| ||||||||
| Japan's Takeda, Dainippon get EU nod for schizophrenia drug TOKYO, March 31 (Reuters) - Takeda Pharmaceutical Co Ltd and Dainippon Sumitomo Pharma Co Ltd said on Monday the European Commission had given them marketing authorisation for Latuda, a once-a-day oral treatment for schizophrenia in adults.
| ||||||||
| In Miss., Medicaid patients struggle to find doctors Mississippi has fewer primary care physicians per capita than any other state, with one primary care physician for every 1,463 citizens. / Jose Elias/iStockphoto, Getty Images Thinkstock. USA Today ...
| ||||||||
Cutting Out TV May Improve Kids' Snacking Habits: Study Discuss, engage, solve, together. Sharing and celebrating the trials and triumphs of contemporary Muslim women. C'est La Vie · Boys Don't Cry · Lessons from International Muslimah Fashion Week · Weighing in on Wedding Season · MORE ARTICLES ...
| ||||||||
Gateway Medical Center officials offer insight into weight-loss surgery Clinical Dietician W.A. Harris and Heather Burgess, coordinator of the Weight Loss/Bariatric Surgery Center, both with Gateway Medical Center, work with the support group for bariatric surgery patients. / THE LEAF-CHRONICLE/ROBERT SMITH ...
| ||||||||
Don't blame medical marijuana legalization for increase in crime rate: Study A new study has shown that legalizing medical marijuana does not increase crime rates. The findings may even the playing field for medical marijuana advocates. (Photo : O'Dea). A new study may finally give medical marijuana advocates the ammunition ...
| ||||||||
Day promotes autism awareness According to a report released last week by the Centers for Disease Control and Prevention, one in 68 U.S. children has an autism spectrum disorder. That is a 30 percent increase from the one-in-88 statistic released two years ago. The Oklahoma Autism ...
| ||||||||
Pranab wants vigil maintained to prevent recurrence of polio India being declared 'polio-free' by the World Health Organisation is a “landmark achievement” and it should now assist countries such as Pakistan, Nigeria and Afghanistan in their fight against this disease by improving their health systems and infrastructure, ...
| ||||||||
Jill Kelly Talks About Jim's Fight Jill Kelly was interviewed as part of a story about her husband, Jim Kelly, as he battles cancer. She says the battle is not fought by Jim alone. "We're all in this together. This isn't just Jim. This isn't just the Kelly family. We're all in this together," she says.
| ||||||||
Prana Biotechnology in pre-open, results pending from Alzheimer's trial The halt was granted pending results of its PBT2 IMAGINE Alzheimer's Disease Phase II Trial. Prana Biotechnology's (ASX: PBT, NASDAQ: PRAN) shares are in pre-open today, following the ASX granting the company a trading halt. The halt was granted ...
| ||||||||
| You have received this email because you have subscribed to Google Alerts. |
 Receive this alert as RSS feed |
| Send Feedback |
No comments:
Post a Comment